TickerFacts.

Maravai Lifesciences Holdings, Inc. (MRVI): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$33.99M
Year ended 2025-12-31
$72.85M
Trailing 12 months to 2026-06-30
-63.8%
3-year compound annual growth
-30.2%
5-year compound annual growth
$714.04M2019-12-31: $76.29M2020-12-31: $204.45M2021-12-31: $658.68M2022-12-31: $714.04M2023-12-31: $140.20M2024-12-31: $108.31M2025-12-31: $33.99M$33.99M
2019-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$33.99M-68.6%2026-02-26, From 2025-01-01
2024-12-31$108.31M-22.7%2026-02-26, From 2024-01-01
2023-12-31$140.20M-80.4%2026-02-26, From 2023-01-01
2022-12-31$714.04M+8.4%2025-03-18, From 2022-01-01
2021-12-31$658.68M+222.2%2024-02-29, From 2021-01-01
2020-12-31$204.45M+168.0%2023-02-28, From 2020-01-01
2019-12-31$76.29Mn/a2022-03-01, From 2019-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Maravai Lifesciences Holdings, Inc. (MRVI)2025-12-31$33.99M-68.6%
Lifevantage Corp (LFVN)2026-06-30$141.61M-22.9%
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$170.26M+45.8%
Cryoport, Inc. (CYRX)2025-12-31$83.05M+19.2%
Phathom Pharmaceuticals, Inc. (PHAT)2025-12-31$152.51M+222.6%
Amarin Corp PLC (AMRN)2025-12-31$120.87M+48.5%
Liquidia Corp (LQDA)2024-12-31$8.12M-44.4%
Heron Therapeutics, Inc. (HRTX)2025-12-31$113.56M+7.5%
Puma Biotechnology, Inc. (PBYI)2025-12-31$170.21M+2.5%

Compare MRVI, LFVN, RYTM, CYRX side by side · Screen every company in Pharmaceutical Preparations ↗